ANGPTL3 orchestrates hepatic fructose sensing and metabolism
Cell Reports · 2025-07 · 44 (7) · 115962
DOI: 10.1016/j.celrep.2025.115962 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025-07. Verfasst von Meng Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA; Stanford Diabetes Research Center, Stanford University Scho…. Hauptthemen laut MEDLINE: Fructose, Angiopoietin-like Proteins, Liver. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIDDK NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Fructose metabolism is linked to metabolic dysfunction-associated steatotic liver disease (MASLD), but the regulatory mechanisms governing fructose uptake remain poorly understood. Here, we demonstrate that MASLD livers exhibit increased uptake of fructose-derived carbons compared to healthy livers and identify that the MASLD hepatocyte secretome can increase fructose metabolism. By performing fractionation and untargeted proteomics, we uncover a role for Angiopoietin-like 3 (ANGPTL3) as a regulator of hepatic fructose metabolism, independent of its role as a lipoprotein lipase (LPL) inhibitor. Circulating ANGPTL3 levels increase in response to fructose exposure, consistent with an action as a fructose sensor. Angptl3 knockdown in the liver resulted in a significant reduction in the uptake of hepatic fructose metabolites in vivo and downregulation of the facilitative hepatic fructose transporter slc2a8 (GLUT8) and fructolysis enzymes. This work demonstrates the existence of extracellular control of hepatic fructose metabolism through ANGPTL3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA; Stanford Diabetes Research Center, Stanford University School of Medicine, Stanford, CA 94305, USA; Stanford Cardiovascular Insti…
- Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA; Department of Chemical and Systems B…
- Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
- Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA; Stanford Cardiovascular Institute, Stanford University School of Medicine, CA, Stanford, USA.
- Macromolecular Structure Knowledge Center (MSKC), Stanford University, Stanford, CA 94305, USA; Stanford ChEM-H, Stanford University, Stanford, CA 94305, USA.
Förderung
- NIAMS NIH HHS
- NIDDK NIH HHS
- NCI NIH HHS
- American Heart Association-American Stroke Association
Zitieren
APA
Zhao, M., Linde-Garelli, K. Y., Zhang, Z., Toomer, D., Reghupaty, S. C., Jimenez, J. I., Coassolo, L., Wat, L. W., Fernandez, D., & Svensson, K. J. (2025). ANGPTL3 orchestrates hepatic fructose sensing and metabolism. Cell Reports, 44(7), 115962. https://doi.org/10.1016/j.celrep.2025.115962
Vancouver
Zhao M, Linde-Garelli KY, Zhang Z, Toomer D, Reghupaty SC, Jimenez JI, et al. ANGPTL3 orchestrates hepatic fructose sensing and metabolism. Cell Reports. 2025;44(7):115962. doi:10.1016/j.celrep.2025.115962
BibTeX
@article{Zhao2025,
author = {Zhao, Meng and Linde-Garelli, Karen Y and Zhang, Zeyuan and Toomer, David and Reghupaty, Saranya C and Jimenez, John Isaiah and Coassolo, Laetitia and Wat, Lianna W and Fernandez, Daniel and Svensson, Katrin J},
title = {ANGPTL3 orchestrates hepatic fructose sensing and metabolism},
journal = {Cell Reports},
year = {2025},
volume = {44},
number = {7},
pages = {115962},
doi = {10.1016/j.celrep.2025.115962}
}
EUVIMED